Pages that link to "Q40999699"
Jump to navigation
Jump to search
The following pages link to Protective immunity against HIV infection: has nature done the experiment for us? (Q40999699):
Displaying 50 items.
- Immunovirological parameters and cytokines in HIV infection (Q26829264) (← links)
- Reduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmission (Q28362322) (← links)
- beta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques (Q33555112) (← links)
- Maternal Trypanosoma cruzi infection upregulates capacity of uninfected neonate cells To produce pro- and anti-inflammatory cytokines (Q33600538) (← links)
- Local control of repeated-dose rectal challenges in DNA/MVA-vaccinated macaques protected against a first series of simian immunodeficiency virus challenges (Q33602810) (← links)
- Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment (Q33782843) (← links)
- DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies (Q33783841) (← links)
- Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus (Q33806129) (← links)
- Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus (Q33808774) (← links)
- Regulation of bovine leukemia virus tax and pol mRNA levels by interleukin-2 and -10. (Q33820243) (← links)
- Role of natural killer cells in resistance against friend retrovirus-induced leukemia (Q33838025) (← links)
- Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes. (Q33839448) (← links)
- Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals (Q34020111) (← links)
- Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzees. (Q34069214) (← links)
- Immunomodulatory effect of zidovudine (ZDV) on cytotoxic T lymphocytes previously exposed to ZDV (Q34113323) (← links)
- Cellular HIV-1 immune responses in natural infection and after genetic immunization. (Q34172130) (← links)
- Increased sensitivity of HIV-1 antibody detection (Q34445202) (← links)
- Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero (Q34461381) (← links)
- Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection. (Q34620836) (← links)
- Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response (Q34949513) (← links)
- Evidence that high-dosage zidovudine at time of retrovirus exposure reduces antiviral efficacy (Q35127088) (← links)
- Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. (Q35372676) (← links)
- Leishmania and human immunodeficiency virus coinfection: the first 10 years (Q35374078) (← links)
- Low maternal viral loads and reduced granulocyte-macrophage colony-stimulating factor levels characterize exposed, uninfected infants who develop protective human immunodeficiency virus type 1-specific responses (Q35783507) (← links)
- Insights into the role of host genetic and T-cell factors in resistance to HIV transmission from studies of highly HIV-exposed Thais (Q35794634) (← links)
- Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection (Q35895554) (← links)
- Vaccine strategies for infectious diseases (Q36181264) (← links)
- Guiding the vaginal microbicide trials with biomarkers of inflammation (Q36371385) (← links)
- Antigen-driven C–C Chemokine-mediated HIV-1 Suppression by CD4+ T Cells from Exposed Uninfected Individuals Expressing the Wild-type CCR-5 Allele (Q36380434) (← links)
- Clinical utilization of chemokines to combat cancer: the double-edged sword (Q36488894) (← links)
- Protective immunity to HIV-1 in SCID/beige mice reconstituted with peripheral blood lymphocytes of exposed but uninfected individuals (Q37050078) (← links)
- Host genetic factors that control immune responses to retrovirus infections (Q37078570) (← links)
- Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure (Q37374425) (← links)
- Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi (Q37387851) (← links)
- Cure for HIV: New possibility on horizon (Q38549079) (← links)
- Type 1 and type 2 cytokine gene expression by viral gp135 surface protein-activated T lymphocytes in caprine arthritis-encephalitis lentivirus infection (Q39880701) (← links)
- Persistently HIV-1 seronegative Nairobi sex workers are susceptible to in vitro infection (Q40662796) (← links)
- Th1/Th2 cytokine responses following HIV-1 immunization in seronegative volunteers. The AIDS Vaccine Evaluation Group (Q40868381) (← links)
- A potent activator of HIV-1 replication is present in the genital tract of a subset of HIV-1-infected and uninfected women (Q41090269) (← links)
- Vaccine strategies: selective elicitation of cellular or humoral immunity? (Q41396041) (← links)
- Human Immunodeficiency Virus type 1 in seronegative infants born to HIV-1-infected mothers (Q42415295) (← links)
- Viral reservoir is suppressed but not eliminated by CD8 vaccine specific lymphocytes (Q43508253) (← links)
- Detecting seronegative-early HIV infections among adult versus student Kenyan blood donors, by using Stimmunology (Q43527701) (← links)
- A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8,DR3 positive subjects: implications for autoimmunity. (Q43651594) (← links)
- The role of type-1 and type-2 T-helper immune responses in HIV-1 vaccine protection. (Q43690745) (← links)
- The maginot line and AIDS vaccines (Q43983296) (← links)
- Recruiting HLA to fight HIV. (Q44042125) (← links)
- Transfusion of red blood cells from an HIV-RNA-positive/anti-HIV-negative donor without HIV infection in the recipient (Q44808902) (← links)
- Occupational exposure to human immunodeficiency virus: what healthcare providers should know (Q45114909) (← links)
- Absence of human immunodeficiency virus infection after intentional injection of infected blood (Q45731959) (← links)